Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $4.0 million.

  • Oncology Institute's Prepaid Assets fell 1190.53% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 1190.53%. This contributed to the annual value of $4.0 million for FY2024, which is 49.39% down from last year.
  • As of FY2024, Oncology Institute's Prepaid Assets stood at $4.0 million, which was down 49.39% from $4.0 million recorded in FY2023.
  • Oncology Institute's 5-year Prepaid Assets high stood at $11.2 million for FY2021, and its period low was $2.1 million during FY2020.
  • In the last 5 years, Oncology Institute's Prepaid Assets had a median value of $4.0 million in 2023 and averaged $5.7 million.
  • As far as peak fluctuations go, Oncology Institute's Prepaid Assets surged by 43105.74% in 2021, and later tumbled by 4147.15% in 2023.
  • Oncology Institute's Prepaid Assets (Annual) stood at $2.1 million in 2020, then skyrocketed by 431.06% to $11.2 million in 2021, then tumbled by 38.23% to $6.9 million in 2022, then tumbled by 41.47% to $4.0 million in 2023, then decreased by 0.49% to $4.0 million in 2024.
  • Its Prepaid Assets stands at $4.0 million for FY2024, versus $4.0 million for FY2023 and $6.9 million for FY2022.